According to research report the global Genome Editing Market is projected to reach USD 6.28 billion by 2022 from USD 3.19 billion in 2017, at a CAGR of 14.5% during the forecast period.
Ask For Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231037000
The key factors propelling the growth of this genome editing market are rising government funding and growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics.
In 2017, North America is projected to have the highest growth rate during the forecast period. Factors such as the development of gene therapy in the US, increasing use of genetically modified crops, rising prevalence of infectious diseases and cancer, and rising availability of research grants and funding are propelling market growth in North America.
Based on technology, the genome engineering market is segmented into CRISPR, TALEN, ZFN, antisense, and other technologies (PiggyBac, Flp-In, Adenine Base Editor (ADE), and Jump-In). The CRISPR segment is expected to register the highest growth during the forecast period. The ease of use associated with the CRISPR technology is a significant advantage over ZFN and TALEN, especially in generating a large set of vectors to target numerous sites or even genome-wide libraries is one of the major factors driving the growth of this segment.
The global genome editing market, by application, is segmented into cell line engineering, genetic engineering, and other applications (diagnostics and therapeutics). The cell line engineering segment is estimated to register the highest growth rate during the forecast period. Factors such as increasing funding from governments and private organizations, growing industry focus on stem cell research, and increasing global awareness about stem cell therapies through various organizations are driving the growth of the cell line engineering segment.
Based on end user, the global genome engineering market is segmented into biotechnology & pharmaceutical companies, academic & government research institutes, and contract research organizations. The biotechnology & pharmaceutical companies’ segment is estimated to register the highest growth rate during the forecast period. The increasing prevalence of infectious diseases and cancer are driving research activities worldwide; this is expected to drive the demand for genome editing in biotechnology & pharmaceutical companies.
Some of the major players in the genome editing market are Thermo Fisher Scientific (US), Merck (Germany), Horizon Discovery Group (UK), GenScript (US), Sangamo BioSciences (US), Integrated DNA Technologies (US), Lonza Group (Switzerland), New England Biolabs (US), OriGene Technologies (US), Transposagen Biopharmaceuticals (US), Editas Medicine (US), and CRISPR Therapeutics (Switzerland).
Request Free Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=231037000
Genome Editing Market Size, Share, Trends - Analysis Report 2022
Jan 22, 2021: Industry InsightsThe global molecular scissors/genome editing market size was worth USD 2,585.5 million in 2016 which is anticipated to grow at a CAGR of more than 13.5% during the forecast period.
Innovative products support the DNA targeting advances with simplicity of AAV packaging for distribution, specificity of the nuclease, and improved flexibility.Furthermore, genome editing is an upcoming stream and biotech & pharmaceutical companies are collaborating for the enhancement of technology.
Several companies are also involved in product manufacturing either on their own or by the asset of strategic partners.
However, factors such as IP disputes in context with CRISPR technology and off-target toxicity issues are anticipated to restrain sector growth.Download sample Copy of This Report at: https://www.millioninsights.com/industry-reports/molecular-scissors-genome-editing-market/request-sampleTechnology InsightsSeveral technologies such as TALENs/MegaTALs, ZFN, and CRISPR are the latest technologies which are applicable in the genome editing field.
Other methods such as Jump-In, Flp-In, PiggyBac, and antisense are applicable for genome engineering.The largest portion was accounted by CRISPR and is anticipated to rule the industry over the forecast period.
Application of innovative technology for the development of novel molecules that can eradicate infectious diseases and hematological malignancies are anticipated to promote the approval of this technology over the forecast period.End-use InsightsThe largest share was attributed by biotechnology organizations as an enormous amount of research is undergoing for development of innovative therapeutics by virtue of molecular scissors.The fastest growth is accounted by government and academic research institutes in the coming years as the adoption rate is increasing for genome engineering technology.
Million Insights Market Research Released A New Research Report On Global Molecular Scissors/Genome Editing Market - Forecast Up To 2025.
Report Provide Overview Of Top Key Players, Share Analysis, Size, Stake, Progress, Trends And Their Strategic Profiling In The Market, Comprehensively Analyzing Their Core Competencies, And Drawing A Competitive Landscape For The Market.
USA: November 6, 2019- Molecular Scissors/Genome Editing Market size was worth USD 2,585.5 million in 2016 which is anticipated to grow at a CAGR of more than 13.5% during the forecast period.
Application of technology in the therapeutic genetic editing process of infected tissue and cells eliminates damage causing mutations, which is expected to enlarge the market size.The existence of robust pipeline products is anticipated to influence progress in genomics sector over the projected period.
Innovative products support the DNA targeting advances with simplicity of AAV packaging for distribution, specificity of the nuclease, and improved flexibility.To Get Sample Report visit @ https://www.millioninsights.com/industry-reports/molecular-scissors-genome-editing-market/request-sampleThe largest market share was accounted by gene therapy and stem cell therapy and is expected to maintain its dominance in the coming years.
Application of innovative technology for the development of novel molecules that can eradicate infectious diseases and hematological malignancies are anticipated to promote the approval of this technology over the forecast period.End-use InsightsThe largest share was attributed by biotechnology organizations as an enormous amount of research is undergoing for development of innovative therapeutics by virtue of molecular scissors.The fastest growth is accounted by government and academic research institutes in the coming years as the adoption rate is increasing for genome engineering technology.
The induced double-strand breaks are repaired through nonhomologous end-joining (NHEJ) or homologous recombination (HR), resulting in targeted mutations.The increasing application of genome engineering in treating chronic ailments and therapeutics will be one of the key factors fueling the growth of genome editing market during the next few years.
With the continuous prevalence of infectious and chronic diseases such as hepatitis, tuberculosis, malaria, HIV/AIDS, and others, the application of genome editing in treating these ailments has increased considerably in the recent years.
According to CDC, there were about 1.8 million new cases of HIV reported in 2016.
Such a rapidly increasing number of HIV cases have led to the researchers to work on new gene-based therapies for reducing morbidity and mortality of HIV-infected patients.
Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-genome-editing-2021-2027-571 Market Analysis and Insights: Global Genome Editing Market The global Genome Editing market size is projected to reach US$ 6739.8 million by 2027, from US$ 3513 million in 2020, at a CAGR of 9.3% during 2021-2027.With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Genome Editing market to help players in achieving a strong market position.
Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Genome Editing market in terms of revenue.On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Genome Editing market.
The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
This study involved the extensive use of both primary and secondary sources.According to the new market research report “ Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), by Technology (Gene Synthesis, Bioinformatics), by Application (Tissue Regeneration, Biofuel, Renewable Energy, Food & Agriculture, Bioremediation) – Global Forecast to 2025“, published by MarketsandMarkets™, synthetic biology market is projected to reach USD 19.8 billion by 2025 from USD 6.8 billion in 2020, at a CAGR of 23.9%.Major Growth Drivers:The growth of this market is primarily attributed to factors such as the increasing demand for synthetic genes & synthetic cells, wide range of applications of synthetic biology, declining cost of DNA sequencing & synthesizing, increasing R funding & initiatives in synthetic biology, and increasing investments in the market.Expected Revenue Growth:[256 Pages Report] The synthetic biology market is projected to reach USD 19.8 billion by 2025 from USD 6.8 billion in 2020, at a CAGR of 23.9%.Accessories to Fuel the Growth of Synthetic Biology Market :The research being conducted in the field of pharmaceuticals, synthetic vaccines, fuel alternatives, textile industry, and green chemicals is expected to propel market growth in the coming years.
Growing initiatives in this field along with the rising R funding activities with the increasing potential of synthetic biology is increasing the adoption of various tools and technologies.
The declining cost of DNA sequencing and synthesizing is improving their adoption which is aiding players to cater to a larger end user base and improve their market share.Browse in-depth TOC on “Synthetic Biology Market”234 – Tables38 – Figures256 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=889By tool, oligonucleotides and synthetic DNA dominated the synthetic biology market in 2019.Based on tools, the market segmented into oligonucleotides and synthetic DNA, enzymes, cloning technology kits, synthetic cells, chassis organisms and xeno-nucleic acid.
In 2019, the oligonucleotides and synthetic DNA segment accounted for the largest share of the market, followed by enzymes.
The large share of the segment can be attributed to the rising demand for synthetic DNA, synthetic RNA, and synthetic genes, which are used in a wide range of research applications.Gene synthesis accounted for the largest share of the synthetic biology market in 2019.Based on technology, the market is segmented into gene synthesis, genome engineering, cloning, sequencing, site-directed mutagenesis, measurement & modeling, microfluidics, nanotechnology, and bioinformatics technologies.
Increasing genomic research across the globe coupled with high incidence of target diseases is expected to stimulate market growth The global Genome Editing market size is expected to reach USD 15.09 Billion by 2028 at a CAGR of 14.8%, according to the latest report by Reports and Data.
Genome editing has come up as promising tool with wide scale application of established genetic engineering technologies such as TALEN and introduction of new methods such as CRISPR technology.The market is driven by the increasing incidence of genetic diseases, favorable funding scenario for research & development in the field of genetic engineering, technological advancements in genetic engineering such as developments in CRISPR technology, increasing focus of food industry on genetically modified organisms, and rising awareness about efficacy as well applications of genetic engineering methods.
For instance, globally over 175 million hectares of land is used for GM crops production.
However, stringent regulatory scenario and ethical concerns for gene editing research and applications and concerns among end users regarding use of gene alteration therapies are likely to hinder the market growth during the forecast period.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1052Some of the key players operating in the Genome Editing market include:genome editing market include Thermo Fisher Scientific Inc., Merck KGaA, GenScript, Horizon Discovery Group Plc, Integrated DNA Technologies, Inc, Lonza, New England Biolabs, and Sangamo Therapeutics, Inc.Segments covered in the report:On the basis of regional analysis, the market is segmented into key geographical regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Asia-Pacific is anticipated to show a significant growth rate owing to rising development and population demands.Type Outlook (Revenue, USD Million, 2017 - 2027)Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)Transcription Activator-Like Effector Nucleases (TALEN)Zinc Finger Nucleases (ZFN)Others Application Outlook (Revenue, USD Million, 2017 - 2027) Animal Genetic EngineeringTherapeutic ApplicationGenetically Modified OrganismsPlant Genetic EngineeringCell Line Engineering Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1052Beneficial Aspects of the Report:Global and region forecast of the Genome Editing market from 2020-2027In-depth analysis of market dynamics, industry outlook, market size based on types and applicationsDetails of value chain analysis, supply and demand ratio, production and consumption patternsSWOT Analysis, Porter’s Five Forces Analysis, Feasibility Analysis, and Investment Return Analysis to provide a better understanding of the market and competitive playersDetailed insights on competitive landscape and emerging market trendsResearch Methodology:The market report is formulated on the basis of data obtained through extensive primary and secondary research.
Global Genome Editing MarketThe investigative study on the Global Genome Editing Market by Reports and Data offers insightful information about the market size and current and emerging trends and elements influencing the growth of the industry on a long term and short term duration.
Moreover, the report also provides key insights to the venture capitalists to make informed decisions about investments in companies.Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1052The report analyzes several key factors that influence the growth of the market or restrain its growth.
COVID-19 infection, which began in late 2019, has been declared as a public health emergency by the WHO.
Not only has the pandemic affected human lives, it has also brought about drastic changes in market dynamics such as supply chain disruptions and economic difficulties.
The report assesses the impact of the COVD-19 pandemic on the market and its key segments in detail.
Some of the key companies profiled in the report include Thermo Fisher Scientific Inc., Merck KGaA, GenScript, Horizon Discovery Group Plc, Integrated DNA Technologies, Inc, Lonza, New England Biolabs and Sangamo Therapeutics, Inc.
This report studies the global Genome Editing market size, industry status and forecast, competition landscape and growth opportunity.
This research report categorizes the global Genome Editing market by companies, region, type and end-use industry.In 2017, the global Genome Editing market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.Request a sample of this report @ http://orbisresearch.com/contacts/request-sample/2212364?utm_source=r0h!tThis report focuses on the global top players, coveredMerck & Co.Bio-Rad Laboratories, Inc.Origene TechnologiesTransposagenClontech LaboratoriesAstra ZenecaAgilent Technologies IncMarket segment by Regions/Countries, this report coversUnited StatesEuropeChinaJapanSoutheast AsiaIndiaMarket segment by Type, the product can be split intoCell – Line EngineeringGene TherapyBiopharmaceutical ProductionMarket segment by Application, split intoBiotechnology IndustryAcademic InstitutionsCROsGovernment Research OrganizationsOthersBrowse the complete report @ http://orbisresearch.com/reports/index/global-genome-editing-market-size-status-and-forecast-2025?utm_source=r0h!tThe study objectives of this report are:To study and forecast the market size of Genome Editing in global market.To analyze the global key players, SWOT analysis, value and global market share for top players.To define, describe and forecast the market by type, end use and region.To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.To identify significant trends and factors driving or inhibiting the market growth.To analyze the opportunities in the market for stakeholders by identifying the high growth segments.To strategically analyze each submarket with respect to individual growth trend and their contribution to the marketTo analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the marketTo strategically profile the key players and comprehensively analyze their growth strategies.In this study, the years considered to estimate the market size of Genome Editing are as follows:History Year: 2013-2017Base Year: 2017Estimated Year: 2018Forecast Year 2018 to 2025For the data information by region, company, type and application, 2017 is considered as the base year.
Whenever data information was unavailable for the base year, the prior year has been considered.Key StakeholdersGenome Editing ManufacturersGenome Editing Distributors/Traders/WholesalersGenome Editing Subcomponent ManufacturersIndustry AssociationDownstream VendorsAvailable CustomizationsWith the given market data, QYResearch offers customizations according to the company's specific needs.
The following customization options are available for the report:Regional and country-level analysis of the Genome Editing market, by end-use.Detailed analysis and profiles of additional market players.Place a purchase order of this report @ http://orbisresearch.com/contact/purchase/2212364?utm_source=r0h!tAbout Us:Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements.
We have vast database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our clients.
Increasing genomic research across the globe coupled with high incidence of target diseases is expected to stimulate market growth The global Genome Editing market size is expected to reach USD 15.09 Billion by 2028 at a CAGR of 14.8%, according to the latest report by Reports and Data.
Genome editing has come up as promising tool with wide scale application of established genetic engineering technologies such as TALEN and introduction of new methods such as CRISPR technology.The market is driven by the increasing incidence of genetic diseases, favorable funding scenario for research & development in the field of genetic engineering, technological advancements in genetic engineering such as developments in CRISPR technology, increasing focus of food industry on genetically modified organisms, and rising awareness about efficacy as well applications of genetic engineering methods.
For instance, globally over 175 million hectares of land is used for GM crops production.
However, stringent regulatory scenario and ethical concerns for gene editing research and applications and concerns among end users regarding use of gene alteration therapies are likely to hinder the market growth during the forecast period.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1052Some of the key players operating in the Genome Editing market include:genome editing market include Thermo Fisher Scientific Inc., Merck KGaA, GenScript, Horizon Discovery Group Plc, Integrated DNA Technologies, Inc, Lonza, New England Biolabs, and Sangamo Therapeutics, Inc.Segments covered in the report:On the basis of regional analysis, the market is segmented into key geographical regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Asia-Pacific is anticipated to show a significant growth rate owing to rising development and population demands.Type Outlook (Revenue, USD Million, 2017 - 2027)Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)Transcription Activator-Like Effector Nucleases (TALEN)Zinc Finger Nucleases (ZFN)Others Application Outlook (Revenue, USD Million, 2017 - 2027) Animal Genetic EngineeringTherapeutic ApplicationGenetically Modified OrganismsPlant Genetic EngineeringCell Line Engineering Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1052Beneficial Aspects of the Report:Global and region forecast of the Genome Editing market from 2020-2027In-depth analysis of market dynamics, industry outlook, market size based on types and applicationsDetails of value chain analysis, supply and demand ratio, production and consumption patternsSWOT Analysis, Porter’s Five Forces Analysis, Feasibility Analysis, and Investment Return Analysis to provide a better understanding of the market and competitive playersDetailed insights on competitive landscape and emerging market trendsResearch Methodology:The market report is formulated on the basis of data obtained through extensive primary and secondary research.
Global Genome Editing MarketThe investigative study on the Global Genome Editing Market by Reports and Data offers insightful information about the market size and current and emerging trends and elements influencing the growth of the industry on a long term and short term duration.
Moreover, the report also provides key insights to the venture capitalists to make informed decisions about investments in companies.Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1052The report analyzes several key factors that influence the growth of the market or restrain its growth.
COVID-19 infection, which began in late 2019, has been declared as a public health emergency by the WHO.
Not only has the pandemic affected human lives, it has also brought about drastic changes in market dynamics such as supply chain disruptions and economic difficulties.
The report assesses the impact of the COVD-19 pandemic on the market and its key segments in detail.
Some of the key companies profiled in the report include Thermo Fisher Scientific Inc., Merck KGaA, GenScript, Horizon Discovery Group Plc, Integrated DNA Technologies, Inc, Lonza, New England Biolabs and Sangamo Therapeutics, Inc.
Jan 22, 2021: Industry InsightsThe global molecular scissors/genome editing market size was worth USD 2,585.5 million in 2016 which is anticipated to grow at a CAGR of more than 13.5% during the forecast period.
Innovative products support the DNA targeting advances with simplicity of AAV packaging for distribution, specificity of the nuclease, and improved flexibility.Furthermore, genome editing is an upcoming stream and biotech & pharmaceutical companies are collaborating for the enhancement of technology.
Several companies are also involved in product manufacturing either on their own or by the asset of strategic partners.
However, factors such as IP disputes in context with CRISPR technology and off-target toxicity issues are anticipated to restrain sector growth.Download sample Copy of This Report at: https://www.millioninsights.com/industry-reports/molecular-scissors-genome-editing-market/request-sampleTechnology InsightsSeveral technologies such as TALENs/MegaTALs, ZFN, and CRISPR are the latest technologies which are applicable in the genome editing field.
Other methods such as Jump-In, Flp-In, PiggyBac, and antisense are applicable for genome engineering.The largest portion was accounted by CRISPR and is anticipated to rule the industry over the forecast period.
Application of innovative technology for the development of novel molecules that can eradicate infectious diseases and hematological malignancies are anticipated to promote the approval of this technology over the forecast period.End-use InsightsThe largest share was attributed by biotechnology organizations as an enormous amount of research is undergoing for development of innovative therapeutics by virtue of molecular scissors.The fastest growth is accounted by government and academic research institutes in the coming years as the adoption rate is increasing for genome engineering technology.
Million Insights Market Research Released A New Research Report On Global Molecular Scissors/Genome Editing Market - Forecast Up To 2025.
Report Provide Overview Of Top Key Players, Share Analysis, Size, Stake, Progress, Trends And Their Strategic Profiling In The Market, Comprehensively Analyzing Their Core Competencies, And Drawing A Competitive Landscape For The Market.
USA: November 6, 2019- Molecular Scissors/Genome Editing Market size was worth USD 2,585.5 million in 2016 which is anticipated to grow at a CAGR of more than 13.5% during the forecast period.
Application of technology in the therapeutic genetic editing process of infected tissue and cells eliminates damage causing mutations, which is expected to enlarge the market size.The existence of robust pipeline products is anticipated to influence progress in genomics sector over the projected period.
Innovative products support the DNA targeting advances with simplicity of AAV packaging for distribution, specificity of the nuclease, and improved flexibility.To Get Sample Report visit @ https://www.millioninsights.com/industry-reports/molecular-scissors-genome-editing-market/request-sampleThe largest market share was accounted by gene therapy and stem cell therapy and is expected to maintain its dominance in the coming years.
Application of innovative technology for the development of novel molecules that can eradicate infectious diseases and hematological malignancies are anticipated to promote the approval of this technology over the forecast period.End-use InsightsThe largest share was attributed by biotechnology organizations as an enormous amount of research is undergoing for development of innovative therapeutics by virtue of molecular scissors.The fastest growth is accounted by government and academic research institutes in the coming years as the adoption rate is increasing for genome engineering technology.
The induced double-strand breaks are repaired through nonhomologous end-joining (NHEJ) or homologous recombination (HR), resulting in targeted mutations.The increasing application of genome engineering in treating chronic ailments and therapeutics will be one of the key factors fueling the growth of genome editing market during the next few years.
With the continuous prevalence of infectious and chronic diseases such as hepatitis, tuberculosis, malaria, HIV/AIDS, and others, the application of genome editing in treating these ailments has increased considerably in the recent years.
According to CDC, there were about 1.8 million new cases of HIV reported in 2016.
Such a rapidly increasing number of HIV cases have led to the researchers to work on new gene-based therapies for reducing morbidity and mortality of HIV-infected patients.
Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-genome-editing-2021-2027-571 Market Analysis and Insights: Global Genome Editing Market The global Genome Editing market size is projected to reach US$ 6739.8 million by 2027, from US$ 3513 million in 2020, at a CAGR of 9.3% during 2021-2027.With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Genome Editing market to help players in achieving a strong market position.
Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Genome Editing market in terms of revenue.On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Genome Editing market.
This report studies the global Genome Editing market size, industry status and forecast, competition landscape and growth opportunity.
This research report categorizes the global Genome Editing market by companies, region, type and end-use industry.In 2017, the global Genome Editing market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.Request a sample of this report @ http://orbisresearch.com/contacts/request-sample/2212364?utm_source=r0h!tThis report focuses on the global top players, coveredMerck & Co.Bio-Rad Laboratories, Inc.Origene TechnologiesTransposagenClontech LaboratoriesAstra ZenecaAgilent Technologies IncMarket segment by Regions/Countries, this report coversUnited StatesEuropeChinaJapanSoutheast AsiaIndiaMarket segment by Type, the product can be split intoCell – Line EngineeringGene TherapyBiopharmaceutical ProductionMarket segment by Application, split intoBiotechnology IndustryAcademic InstitutionsCROsGovernment Research OrganizationsOthersBrowse the complete report @ http://orbisresearch.com/reports/index/global-genome-editing-market-size-status-and-forecast-2025?utm_source=r0h!tThe study objectives of this report are:To study and forecast the market size of Genome Editing in global market.To analyze the global key players, SWOT analysis, value and global market share for top players.To define, describe and forecast the market by type, end use and region.To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.To identify significant trends and factors driving or inhibiting the market growth.To analyze the opportunities in the market for stakeholders by identifying the high growth segments.To strategically analyze each submarket with respect to individual growth trend and their contribution to the marketTo analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the marketTo strategically profile the key players and comprehensively analyze their growth strategies.In this study, the years considered to estimate the market size of Genome Editing are as follows:History Year: 2013-2017Base Year: 2017Estimated Year: 2018Forecast Year 2018 to 2025For the data information by region, company, type and application, 2017 is considered as the base year.
Whenever data information was unavailable for the base year, the prior year has been considered.Key StakeholdersGenome Editing ManufacturersGenome Editing Distributors/Traders/WholesalersGenome Editing Subcomponent ManufacturersIndustry AssociationDownstream VendorsAvailable CustomizationsWith the given market data, QYResearch offers customizations according to the company's specific needs.
The following customization options are available for the report:Regional and country-level analysis of the Genome Editing market, by end-use.Detailed analysis and profiles of additional market players.Place a purchase order of this report @ http://orbisresearch.com/contact/purchase/2212364?utm_source=r0h!tAbout Us:Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements.
We have vast database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our clients.
The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
This study involved the extensive use of both primary and secondary sources.According to the new market research report “ Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), by Technology (Gene Synthesis, Bioinformatics), by Application (Tissue Regeneration, Biofuel, Renewable Energy, Food & Agriculture, Bioremediation) – Global Forecast to 2025“, published by MarketsandMarkets™, synthetic biology market is projected to reach USD 19.8 billion by 2025 from USD 6.8 billion in 2020, at a CAGR of 23.9%.Major Growth Drivers:The growth of this market is primarily attributed to factors such as the increasing demand for synthetic genes & synthetic cells, wide range of applications of synthetic biology, declining cost of DNA sequencing & synthesizing, increasing R funding & initiatives in synthetic biology, and increasing investments in the market.Expected Revenue Growth:[256 Pages Report] The synthetic biology market is projected to reach USD 19.8 billion by 2025 from USD 6.8 billion in 2020, at a CAGR of 23.9%.Accessories to Fuel the Growth of Synthetic Biology Market :The research being conducted in the field of pharmaceuticals, synthetic vaccines, fuel alternatives, textile industry, and green chemicals is expected to propel market growth in the coming years.
Growing initiatives in this field along with the rising R funding activities with the increasing potential of synthetic biology is increasing the adoption of various tools and technologies.
The declining cost of DNA sequencing and synthesizing is improving their adoption which is aiding players to cater to a larger end user base and improve their market share.Browse in-depth TOC on “Synthetic Biology Market”234 – Tables38 – Figures256 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=889By tool, oligonucleotides and synthetic DNA dominated the synthetic biology market in 2019.Based on tools, the market segmented into oligonucleotides and synthetic DNA, enzymes, cloning technology kits, synthetic cells, chassis organisms and xeno-nucleic acid.
In 2019, the oligonucleotides and synthetic DNA segment accounted for the largest share of the market, followed by enzymes.
The large share of the segment can be attributed to the rising demand for synthetic DNA, synthetic RNA, and synthetic genes, which are used in a wide range of research applications.Gene synthesis accounted for the largest share of the synthetic biology market in 2019.Based on technology, the market is segmented into gene synthesis, genome engineering, cloning, sequencing, site-directed mutagenesis, measurement & modeling, microfluidics, nanotechnology, and bioinformatics technologies.